FDA: Political pressure led to device OK

The FDA said Thursday that four New Jersey congressmen and its own former commissioner unduly influenced the process that led to its decision last year to approve a patch for injured knees, an approval it is now revisiting. Report

Suggested Articles

tecentriq
Pharma

Roche's Tecentriq scores first-in-class liver cancer nod

After years of having first-line liver cancer market to itself, Bayer’s Nexavar is getting major competition from Roche's Tecentriq.

by Carly Helfand
abbvie
Pharma

AbbVie scores 'game-changer' nod for Oriahnn in uterine fibroids

Most of the recent enthusiasm around AbbVie’s new drugs has centered on Skyrizi and Rinvoq, but elagolix wants a piece of the spotlight, too.

by Carly Helfand
Pharma

Sanofi loses vaccines chief Loew to Ipsen amid C-suite shakeup

During David Loew's tenure, Sanofi Pasteur bought Protein Sciences, whose recombinant technology is being applied to a COVID-19 vaccine.

by Angus Liu